PRT-064040
/ Sichuan Purity Pharmaceutical Technology
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
January 30, 2026
Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults
(clinicaltrials.gov)
- P2 | N=456 | Recruiting | Sponsor: Sichuan Purity Pharmaceutical Technology Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • CNS Disorders • Migraine • Pain
December 27, 2025
Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults
(clinicaltrials.gov)
- P2 | N=456 | Not yet recruiting | Sponsor: Sichuan Purity Pharmaceutical Technology Co., Ltd.
New P2 trial • CNS Disorders • Migraine • Pain
December 05, 2025
A Study to Learn About PRT-064040 Nasal Spray in Healthy Adult Subjects
(clinicaltrials.gov)
- P1 | N=80 | Completed | Sponsor: Sichuan Purity Pharmaceutical Technology Co., Ltd. | Recruiting ➔ Completed
Trial completion • CNS Disorders • Migraine • Pain
June 16, 2025
A Study to Learn About PRT-064040 Nasal Spray in Healthy Adult Subjects
(clinicaltrials.gov)
- P1 | N=80 | Recruiting | Sponsor: Sichuan Purity Pharmaceutical Technology Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • CNS Disorders • Migraine • Pain
June 11, 2025
A Study to Learn About PRT-064040 Nasal Spray in Healthy Adult Subjects
(clinicaltrials.gov)
- P1 | N=80 | Not yet recruiting | Sponsor: Sichuan Purity Pharmaceutical Technology Co., Ltd.
New P1 trial • CNS Disorders • Migraine • Pain
1 to 5
Of
5
Go to page
1